Leidos · 1 day ago
Senior Quantitative Analyst
Maximize your interview chances
ComputerGovernment
Actively HiringNo H1BSecurity Clearance Required
Insider Connection @Leidos
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Working with customer to refine a problem and translate into something that can be answered with a model and the available data
Developing in and extending an agent-based framework to support infectious disease and other response activities
Guiding colleagues through an analytic process, often in situations with high uncertainty and/or limited data
Performing ad-hoc analyses on existing data
Performing novel statistical analyses of clinical trial results
Performing the entire lifecycle of analysis: problem formulation, data acquisition, data cleaning, analysis, and presentation
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
MS in relevant discipline with 6+ years relevant experience OR PhD in relevant discipline with 2+ years relevant experience
U.S Citizenship; Currently possess an active DoD Secret Clearance or ability to obtain/maintain upon hire.
Expertise in mathematics, probability and statistics, data science
Experience with scientific or mathematical software or programming; particularly R or other scripting language (e.g. Python, MATLAB, or Mathematica)
Experience developing software in an object-oriented programming language (Java programming is considered a strong plus)
Excellent communication skills with the ability to successfully interact with supervisors, functional peer groups, and/or outside customers
Demonstrated ability to quickly learn new mathematical, statistical, and computational techniques, as well as new subject areas (epidemiology, virology, radiation injury, etc)
Preferred
Subject matter knowledge of quantitative epidemiology, avian/pandemic influenza, and/or related sciences
Subject matter knowledge of CBRN effects, risks
Company
Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world’s most vexing challenges in national security and health.
Funding
Current Stage
Public CompanyTotal Funding
unknown2013-09-17IPO
Leadership Team
Recent News
Yahoo Finance
2024-12-11
2024-12-06
MarketScreener
2024-12-04
Company data provided by crunchbase